These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658 [TBL] [Abstract][Full Text] [Related]
3. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity. Broxterman HJ; Sonneveld P; Feller N; Ossenkoppele GJ; Währer DC; Eekman CA; Schoester M; Lankelma J; Pinedo HM; Löwenberg B; Schuurhuis GJ Blood; 1996 Jun; 87(11):4809-16. PubMed ID: 8639853 [TBL] [Abstract][Full Text] [Related]
4. Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds. Versantvoort CH; Rhodes T; Twentyman PR Br J Cancer; 1996 Dec; 74(12):1949-54. PubMed ID: 8980395 [TBL] [Abstract][Full Text] [Related]
5. Use of the anionic dye carboxy-2',7'-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity. Laupeze B; Amiot L; Courtois A; Vernhet L; Drenou B; Fauchet R; Fardel O Int J Oncol; 1999 Sep; 15(3):571-6. PubMed ID: 10427142 [TBL] [Abstract][Full Text] [Related]
6. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia. den Boer ML; Pieters R; Kazemier KM; Janka-Schaub GE; Henze G; Veerman AJ Leukemia; 1998 Jun; 12(6):912-20. PubMed ID: 9639420 [TBL] [Abstract][Full Text] [Related]
7. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells. Gollapudi S; Kim CH; Tran BN; Sangha S; Gupta S Cancer Chemother Pharmacol; 1997; 40(2):150-8. PubMed ID: 9182837 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P. Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360 [TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Essodaigui M; Broxterman HJ; Garnier-Suillerot A Biochemistry; 1998 Feb; 37(8):2243-50. PubMed ID: 9485370 [TBL] [Abstract][Full Text] [Related]
10. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts. Pallis M; Turzanski J; Langabeer S; Russell NH Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783 [TBL] [Abstract][Full Text] [Related]
11. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Versantvoort CH; Bagrij T; Wright KA; Twentyman PR Int J Cancer; 1995 Dec; 63(6):855-62. PubMed ID: 8847145 [TBL] [Abstract][Full Text] [Related]
12. A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells. Homolya L; Holló M; Müller M; Mechetner EB; Sarkadi B Br J Cancer; 1996 Apr; 73(7):849-55. PubMed ID: 8611394 [TBL] [Abstract][Full Text] [Related]
13. Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP. Germann UA; Ford PJ; Shlyakhter D; Mason VS; Harding MW Anticancer Drugs; 1997 Feb; 8(2):141-55. PubMed ID: 9073310 [TBL] [Abstract][Full Text] [Related]
14. Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Legrand O; Simonin G; Perrot JY; Zittoun R; Marie JP Blood; 1998 Jun; 91(12):4480-8. PubMed ID: 9616142 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Castro AF; Altenberg GA Biochem Pharmacol; 1997 Jan; 53(1):89-93. PubMed ID: 8960067 [TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein-independent decrease in drug accumulation by phorbol ester treatment of tumor cells. Wielinga PR; Heijn M; Broxterman HJ; Lankelma J Biochem Pharmacol; 1997 Oct; 54(7):791-9. PubMed ID: 9353133 [TBL] [Abstract][Full Text] [Related]
17. A novel bioassay for P-glycoprotein functionality using cytochalasin D. Elbling L; Berger W; Weiss RM; Printz D; Fritsch G; Micksche M Cytometry; 1998 Mar; 31(3):187-98. PubMed ID: 9515718 [TBL] [Abstract][Full Text] [Related]
18. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695 [TBL] [Abstract][Full Text] [Related]
19. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. Draper MP; Martell RL; Levy SB Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400 [TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance-related proteins in primary choroidal melanomas and in vitro cell lines. van der Pol JP; Blom DJ; Flens MJ; Luyten GP; de Waard-Siebinga I; Koornneef L; Scheper RJ; Jager MJ Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2523-30. PubMed ID: 9375571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]